During the past decade, AOU San Giovanni di Dio e Ruggi D'Aragona conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 10 clinical trials were completed, i.e. on average, 32.3% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 10 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AOU San Giovanni di Dio e Ruggi D'Aragona" #1 sponsor was "Biogen" with 3 trials, followed by "Theravance Biopharma" with 3 trials sponsored, "Abbott Medical Devices" with 2 trials sponsored, "Associazione Qol-one" with 2 trials sponsored and "Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona" with 2 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AOU San Giovanni di Dio e Ruggi D'Aragona" #1 collaborator was "Federico II University" with 2 trials as a collaborator, "University of Modena and Reggio Emilia" with 2 trials as a collaborator, "AdvicePharma Group" with 1 trials as a collaborator, "Azienda Ospedaliera di Padova" with 1 trials as a collaborator and "Azienda Ospedaliero, Universitaria Pisana" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "AOU San Giovanni di Dio e Ruggi D'Aragona" are "Coronary Artery Disease" (3 trials), "Parkinson's Disease" (3 trials), "Symptomatic Neurogenic Orthostatic Hypotension" (3 trials), "Acute Myeloid Leukemia" (2 trials) and "Alzheimer's Disease" (2 trials). Many other conditions were trialed in "AOU San Giovanni di Dio e Ruggi D'Aragona" in a lesser frequency.

Most popular intervention types in "AOU San Giovanni di Dio e Ruggi D'Aragona" are "Drug" (26 trials), "Other" (8 trials) and "Device" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "ampreloxetine" (3 trials), "Accordion Pill™ Carbidopa/Levodopa" (2 trials), "Avapritinib" (2 trials) and "GED-0301" (2 trials). Other intervention names were less common.

The vast majority of trials in "AOU San Giovanni di Dio e Ruggi D'Aragona" are 34 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "AOU San Giovanni di Dio e Ruggi D'Aragona". undefined are not yet recruiting, 5 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in AOU San Giovanni di Dio e Ruggi D'Aragona, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in AOU San Giovanni di Dio e Ruggi D'Aragona, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 2 trials that are defined as “Not Applicable".

AOU San Giovanni di Dio e Ruggi D'Aragona has several departments that took part in Clinical trials: "Aou S. Giovanni Di Dio-Ruggi D'Aragona - Cardiologia Interventistica - Emodinamic" - 2 trials, "A.O.U.S. Giovanni e Ruggi d'Aragona UOC UTIC" - 2 trials